首页 › 滤泡性淋巴瘤 › 威斯康星州 › Milwaukee
Milwaukee WI 滤泡性淋巴瘤临床试验
19项针对 滤泡性淋巴瘤的研究正在 Milwaukee及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
招募中3 期
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 距离 11 英里
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 距离 11 英里
- 以及另外 3 项
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
招募中观察性研究
- Children's Hospital of Wisconsin, Milwaukee
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
招募中欢迎健康志愿者
- Vivent Health, Milwaukee
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
招募中1 期
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
招募中1 期
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
招募中3 期
- Research Site, Milwaukee
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
招募中2 期
- Research Site, Milwaukee
A Study of ARC-02 in B-cell NHL
招募中1 期
- Froedtert & Medical College of Wisconsin, Milwaukee
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
招募中1/2 期
- Medical College of Wisconsin, Milwaukee
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
招募中3 期
- Prohealth Care Inc, Waukesha · 距离 17 英里
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
招募中1 期
- Froedtert & the Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- Medical College of Wisconsin, Milwaukee
Epcoritamab and Rituximab for First-line Follicular Lymphoma
招募中2 期
- Medical College of Wisconsin, Milwaukee
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
招募中1/2 期
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Study of SGR-1505 in Mature B-Cell Neoplasms
招募中1 期
- Medical College of Wisconsin, Milwaukee
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
招募中1 期
- The Medical College of Wisconsin, Milwaukee
Long-term Follow-up Study of Patients Receiving CAR-T Cells
招募中观察性研究
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Milwaukee
A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
招募中观察性研究
- CIBMTR, Milwaukee
其他城市的 滤泡性淋巴瘤试验
- New York City, NY24 项研究
- Nashville, TN18 项研究
- Houston, TX18 项研究
- Boston, MA17 项研究
- Baldwin Park, CA16 项研究
- Seattle, WA15 项研究
- Durham, NC15 项研究
- Columbus, OH13 项研究
- Salt Lake City, UT13 项研究
- Chicago, IL12 项研究
- San Antonio, TX12 项研究
- Philadelphia, PA12 项研究
Milwaukee的其他研究
- 乳腺癌23 项研究
- 非小细胞肺癌22 项研究
- 癌症（所有类型）22 项研究
- 肺癌21 项研究
- 多发性骨髓瘤21 项研究
- 前列腺癌20 项研究
- 胰腺癌18 项研究
- 非霍奇金淋巴瘤18 项研究
- 卵巢癌17 项研究
- 急性髓系白血病17 项研究
- 伯基特淋巴瘤16 项研究
- 心力衰竭16 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。